Answers are grounded in this paper and cite their sources.
The effect of infusing DDAVP and cryoprecipitate either singly or in combination was studied in a patient with variant von Willebrand disease. Both DDAVP and cryoprecipitate caused only partial correction in the hemostatic defect when used as a single agent. A combination of DDAVP and cryoprecipitate induced a complete correction of the hemostatic defect as well as factor VIII related properties.
No takes yet. Share an insight, caveat, or question.
Hanna et al. (1985) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: